related_tweet: convalescent plasma therapy, in immunocompromised/immunosuppressed patients may lead to emergence of viral variants as part of evolutionary mechanisms due to selection pressure, that shows evidence of reduced susceptibility to neutralizing abs in immunosuppressed individuals.